CCL2 and Parkinson disease: BV attenuated motor impairment, decreased oxidative/nitrosative stress, and TNF-α, Caspase-3, and monocyte chemoattractant protein-1 (MCP-1) expression, and increased dopamine (DA) content and butyrylcholinesterase (BuChE) activity in a rotenone-induced PD mice model (Badawi et al., 2020).